¼¼°èÀÇ »ý¸í°úÇÐ BPO ½ÃÀå
Life Sciences BPO
»óǰÄÚµå : 1655397
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 02¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 196 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,464,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 25,393,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°èÀÇ »ý¸í°úÇÐ BPO ½ÃÀå, 2030³â±îÁö 5,578¾ï ´Þ·¯¿¡ µµ´Þ

2024³â¿¡ 3,826¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ¼¼°èÀÇ »ý¸í°úÇÐ BPO ½ÃÀåÀº 2030³â¿¡´Â 5,578¾ï ´Þ·¯¿¡ ´ÞÇϸç, ºÐ¼® ±â°£ÀÎ 2024-2030³âÀÇ CAGRÀº 6.5%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ ¸®Æ÷Æ®¿¡¼­ ºÐ¼®ÇÑ ºÎ¹®ÀÇ ÇϳªÀÎ ÀǾàǰ ¾Æ¿ô¼Ò½Ì ¼­ºñ½º´Â CAGR 6.4%¸¦ ±â·ÏÇϸç, ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 2,818¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÇ·á±â±â ¾Æ¿ô¼Ò½Ì ¼­ºñ½º ºÐ¾ßÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ Áß CAGR 7.2%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 1,058¾ï ´Þ·¯, Áß±¹Àº CAGR 6.2%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹Ãø

¹Ì±¹ÀÇ »ý¸í°úÇÐ BPO ½ÃÀåÀº 2024³â¿¡ 1,058¾ï ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ÀÇ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 870¾ï ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2024-2030³âÀÇ CAGRÀº 6.2%ÀÔ´Ï´Ù. ±âŸ ÁÖ¸ñÇØ¾ß ÇÒ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ Áß CAGRÀº °¢°¢ 6.2%¿Í 5.3%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 5.3%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ »ý¸í°úÇÐ BPO ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

»ý¸í°úÇÐ »ê¾÷¿¡¼­ ºñÁî´Ï½º ÇÁ·Î¼¼½º ¾Æ¿ô¼Ò½Ì(BPO)ÀÌ Áß¿äÇÑ ÀÌÀ¯´Â ¹«¾ùÀΰ¡?

ºñÁî´Ï½º ÇÁ·Î¼¼½º ¾Æ¿ô¼Ò½Ì(BPO)Àº ±â¾÷ÀÌ ¿î¿µ ºñ¿ëÀ» Àý°¨Çϰí, È¿À²¼ºÀ» ³ôÀ̰í, R&D¿Í °°Àº ÇÙ½É ¿ª·®¿¡ ÁýÁßÇϱâ À§ÇØ »ý¸í°úÇÐ »ê¾÷¿¡¼­ Á¡Á¡ ´õ Áß¿äÇØÁö°í ÀÖ½À´Ï´Ù. ÀÓ»ó½ÃÇè °ü¸®, ±ÔÁ¦ Áؼö, µ¥ÀÌÅÍ °ü¸®¿Í °°Àº ºñÇÙ½É ¾÷¹«¸¦ ¾Æ¿ô¼Ò½ÌÇÔÀ¸·Î½á »ý¸í°úÇÐ ±â¾÷Àº Àü¹® BPO ÇÁ·Î¹ÙÀÌ´õÀÇ Àü¹®¼ºÀ» Ȱ¿ëÇϸ鼭 Çõ½Å°ú Á¦Ç° °³¹ß¿¡ ÀÚ¿øÀ» ÁýÁßÇÒ ¼ö ÀÖ½À´Ï´Ù. º¹ÀâÇØÁö´Â ±ÔÁ¦ ¿ä°Ç, ºñ¿ë È¿À²ÀûÀÎ ¼Ö·ç¼ÇÀÇ Çʿ伺, ½ÅÁ¦Ç° Ãâ½Ã ½Ã°£ ´ÜÃà¿¡ ´ëÇÑ ¾Ð¹ÚÀ¸·Î ÀÎÇØ »ý¸í°úÇÐ »ê¾÷¿¡¼­ BPO ¼­ºñ½º µµÀÔÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

±â¼úÀÇ ¹ßÀüÀº »ý¸í°úÇÐ BPO ½ÃÀåÀ» ¾î¶»°Ô Çü¼ºÇϰí Àִ°¡?

±â¼úÀÇ ¹ßÀüÀº »ý¸í°úÇÐ BPO ¼­ºñ½º ¿ª·® °­È­¿¡ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. Ŭ¶ó¿ìµå ÄÄÇ»ÆÃ, ÀΰøÁö´É(AI), ·Îº¿ ÇÁ·Î¼¼½º ÀÚµ¿È­(RPA)¿Í °°Àº µðÁöÅÐ ±â¼úÀÇ ÅëÇÕÀº BPO ÇÁ·Î¹ÙÀÌ´õ°¡ º¸´Ù È¿À²ÀûÀ̰í È®Àå °¡´ÉÇϸç Á¤È®ÇÑ ¼­ºñ½º¸¦ Á¦°øÇÒ ¼ö ÀÖµµ·Ï µ½°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼úÀº BPO ÇÁ·Î¹ÙÀÌ´õ°¡ ÇÁ·Î¼¼½º¸¦ °£¼ÒÈ­Çϰí, ÀÎÀû ¿À·ù¸¦ ÁÙÀ̰í, µ¥ÀÌÅÍ Á¤È®µµ¿Í ±ÔÁ¤ Áؼö¸¦ Çâ»ó½ÃŰ´Â µ¥ µµ¿òÀÌ µÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ µ¥ÀÌÅÍ ºÐ¼®°ú ¸Ó½Å·¯´×ÀÇ ¹ßÀüÀ¸·Î BPO ÇÁ·Î¹ÙÀÌ´õµéÀº ÀÓ»ó½ÃÇè ¿¹Ãø ºÐ¼®, ÀǾàǰ Çã°¡ ½Åû ÀÚµ¿È­ µî ´õ¿í °íµµÈ­µÈ ¼­ºñ½º¸¦ Á¦°øÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼ú Çõ½ÅÀº ¾÷¹« È¿À²À» ³ôÀÌ°í ºñ¿ëÀ» Àý°¨ÇϰíÀÚ ÇÏ´Â ±â¾÷ÀÌ »ý¸í°úÇÐ »ê¾÷¿¡¼­ BPO ¼­ºñ½º¸¦ µµÀÔÇÏ´Â µ¥ Å« µµ¿òÀÌ µÇ°í ÀÖ½À´Ï´Ù.

»ý¸í°úÇÐ »ê¾÷¿¡¼­ BPO ¼­ºñ½º µµÀÔÀ» ÃËÁøÇÏ´Â µ¿ÇâÀº ¹«¾ùÀΰ¡?

»ý¸í°úÇÐ »ê¾÷¿¡¼­ BPO ¼­ºñ½º¸¦ µµÀÔÇÏ´Â µ¥¿¡´Â ÀÓ»ó½ÃÇèÀÇ º¹À⼺ Áõ°¡, ±ÔÁ¦ Áؼö¿¡ ´ëÇÑ Á߿伺, ºñ¿ë È¿À²ÀûÀÎ ¼Ö·ç¼ÇÀÇ Çʿ伺 µî ¸î °¡Áö Áß¿äÇÑ µ¿ÇâÀÌ ÀÖ½À´Ï´Ù. º¹ÀâÇÏ°í ¼¼°èÇÑ ÀÓ»ó½ÃÇèÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ÀÌ·¯ÇÑ ÀÓ»ó½ÃÇèÀ» È¿À²ÀûÀ¸·Î °ü¸®ÇÏ°í ±ÔÁ¦ ¿ä°ÇÀ» ÁؼöÇÒ ¼ö ÀÖ´Â Àü¹® BPO ¼­ºñ½º¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ±ÔÁ¦°¡ º¹ÀâÇØÁö¸é¼­ ±ÔÁ¦ Áؼö¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁø °Íµµ »ý¸í°úÇÐ ±â¾÷ÀÌ ±ÔÁ¦ Áؼö¿¡ ´ëÇÑ ºñ¿ë ºÎ´ã°ú ó¹úÀ» ÇÇÇϱâ À§ÇØ Àü¹® BPO ¾÷ü¿¡ ±ÔÁ¦ Áؼö ¾÷¹«¸¦ ¾Æ¿ô¼Ò½ÌÇÏ´Â µ¥¿¡ ÈûÀ» ½Ç¾îÁÖ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ °æÀïÀÌ Ä¡¿­ÇÑ ½ÃÀå¿¡¼­´Â ºñ¿ë È¿À²ÀûÀÎ ¼Ö·ç¼ÇÀÌ ÇÊ¿äÇϹǷΠ±â¾÷Àº ¿î¿µ ºñ¿ëÀ» Àý°¨ÇÏ°í ¼öÀͼºÀ» °³¼±Çϱâ À§ÇØ BPO ¼­ºñ½º¸¦ µµÀÔÇÏ´Â °æÇâÀÌ ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Ãß¼¼´Â »ý¸í°úÇÐ BPO ½ÃÀåÀÇ ¿ªµ¿ÀûÀÎ ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.

»ý¸í°úÇÐ BPO ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ¿äÀÎÀº ¹«¾ùÀΰ¡?

»ý¸í°úÇÐ BPO ½ÃÀåÀÇ ¼ºÀåÀº ºñ¿ë È¿À²ÀûÀ̰í È¿À²ÀûÀÎ ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, ±ÔÁ¦ ¿ä°ÇÀÇ º¹À⼺, ÀÓ»ó½ÃÇè ¹× ±ÔÁ¦ Ȱµ¿ °ü¸®¿¡ ´ëÇÑ Àü¹®Àû Àü¹® Áö½ÄÀÇ Çʿ伺 µî ¿©·¯ ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ Á¦¾à ¹× »ý¸í°øÇÐ »ê¾÷ÀÇ ¼ºÀå°ú ½ÅÁ¦Ç° Ãâ½Ã ½Ã°£ ´ÜÃà¿¡ ´ëÇÑ ¾Ð¹Úµµ BPO ¼­ºñ½º äÅÃÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ µðÁöÅÐ ÀüȯÀÇ ºÎ»ó°ú AI ¹× ÀÚµ¿È­¿Í °°Àº ÷´Ü ±â¼úÀÇ ÅëÇÕÀº BPO ÇÁ·Î¹ÙÀÌ´õÀÇ ¿ª·®À» °­È­ÇÏ°í ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù. »ý¸í°úÇÐ ±â¾÷ÀÌ ÇÙ½É ¿ª·®¿¡ ÁýÁßÇÒ ¼ö ÀÖ´Â ¾÷¹« ÃÖÀûÈ­ ¹æ¾ÈÀ» ¸ð»öÇϸ鼭 BPO ¼­ºñ½º¿¡ ´ëÇÑ ¼ö¿ä´Â Áö¼ÓÀûÀ¸·Î Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ºÎ¹®

¼­ºñ½º À¯Çü(ÀǾàǰ ¾Æ¿ô¼Ò½Ì ¼­ºñ½º, ÀÇ·á±â±â ¾Æ¿ô¼Ò½Ì ¼­ºñ½º, ¿µ¾÷ ¹× ¸¶ÄÉÆÃ ¾Æ¿ô¼Ò½Ì ¼­ºñ½º, ±âŸ ¼­ºñ½º À¯Çü)

Á¶»ç ´ë»ó ±â¾÷ÀÇ ¿¹(ÁÖ¸ñ 46»ç)

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå °³¿ä

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Life Sciences BPO Market to Reach US$557.8 Billion by 2030

The global market for Life Sciences BPO estimated at US$382.6 Billion in the year 2024, is expected to reach US$557.8 Billion by 2030, growing at a CAGR of 6.5% over the analysis period 2024-2030. Pharmaceutical Outsourcing Services, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$281.8 Billion by the end of the analysis period. Growth in the Medical Device Outsourcing Services segment is estimated at 7.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$105.8 Billion While China is Forecast to Grow at 6.2% CAGR

The Life Sciences BPO market in the U.S. is estimated at US$105.8 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$87.0 Billion by the year 2030 trailing a CAGR of 6.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.2% and 5.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.3% CAGR.

Global Life Sciences BPO Market - Key Trends & Drivers Summarized

Why Is Business Process Outsourcing (BPO) Becoming Critical in the Life Sciences Industry?

Business Process Outsourcing (BPO) is becoming increasingly critical in the life sciences industry as companies seek to reduce operational costs, improve efficiency, and focus on core competencies such as research and development. By outsourcing non-core activities, such as clinical trials management, regulatory compliance, and data management, life sciences companies can leverage the expertise of specialized BPO providers while freeing up resources to concentrate on innovation and product development. The growing complexity of regulatory requirements, the need for cost-effective solutions, and the pressure to accelerate time-to-market for new products are driving the adoption of BPO services in the life sciences industry.

How Are Technological Advancements Shaping the Life Sciences BPO Market?

Technological advancements are playing a significant role in enhancing the capabilities of life sciences BPO services. The integration of digital technologies, such as cloud computing, artificial intelligence (AI), and robotic process automation (RPA), is enabling BPO providers to offer more efficient, scalable, and accurate services. These technologies are helping BPO providers streamline processes, reduce human error, and improve data accuracy and compliance. Additionally, advancements in data analytics and machine learning are allowing BPO providers to offer more sophisticated services, such as predictive analytics for clinical trials and automated regulatory submissions. These technological innovations are driving the adoption of BPO services in the life sciences industry, as companies seek to enhance operational efficiency and reduce costs.

What Trends Are Driving the Adoption of BPO Services in the Life Sciences Industry?

Several key trends are driving the adoption of BPO services in the life sciences industry, including the increasing complexity of clinical trials, the growing emphasis on regulatory compliance, and the need for cost-effective solutions. The rise of complex and global clinical trials is driving demand for specialized BPO services that can manage these trials efficiently and ensure compliance with regulatory requirements. The growing focus on regulatory compliance, driven by the increasing complexity of regulations and the need to avoid costly delays and penalties, is also encouraging life sciences companies to outsource regulatory activities to specialized BPO providers. Additionally, the need for cost-effective solutions in a competitive market is driving companies to adopt BPO services to reduce operational costs and improve profitability. These trends are contributing to the dynamic growth of the life sciences BPO market.

What Factors Are Driving the Growth of the Life Sciences BPO Market?

The growth in the life sciences BPO market is driven by several factors, including the increasing demand for cost-effective and efficient solutions, the growing complexity of regulatory requirements, and the need for specialized expertise in managing clinical trials and regulatory activities. The expansion of the pharmaceutical and biotechnology industries, coupled with the pressure to accelerate time-to-market for new products, is also driving the adoption of BPO services. Additionally, the rise of digital transformation and the integration of advanced technologies, such as AI and automation, are enhancing the capabilities of BPO providers and driving market growth. As life sciences companies continue to seek ways to optimize their operations and focus on core competencies, the demand for BPO services is expected to experience sustained growth.

SCOPE OF STUDY:

The report analyzes the Life Sciences BPO market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Service Type (Pharmaceutical Outsourcing Services, Medical Device Outsourcing Services, Sales & Marketing Outsourcing Services, Other Service Types)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 46 Featured) -

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â